Novanta Inc. - Common Shares (NOVT)

149.66Last Price

+0.59 (0.40%)Change

Novanta Inc is a global provider of advanced technology solutions that cater to the medical and advanced industrial markets

The company specializes in the design and manufacturing of photonics, motion, and precision optics systems, which are critical in enabling precise and efficient functioning of various applications, such as surgical equipment, laser-based technologies, and automated industrial processes. With a focus on innovation and quality, Novanta works closely with its customers to develop tailored solutions that enhance performance and reliability in demanding environments, ultimately contributing to improved outcomes in healthcare and productivity across various industries.

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025.

By Novanta Inc. · Via Business Wire · January 28, 2025

Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that management will be participating at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025, which is being held virtually.

By Novanta Inc. · Via Business Wire · December 19, 2024

Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025, in San Francisco, California.

By Novanta Inc. · Via Business Wire · December 18, 2024

Novanta Announces Financial Results for the Third Quarter 2024

Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024.

By Novanta Inc. · Via Business Wire · November 5, 2024

Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois.

By Novanta Inc. · Via Business Wire · October 15, 2024

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024.

By Novanta Inc. · Via Business Wire · October 8, 2024

Novanta Announces Financial Results for the Second Quarter 2024

By Novanta Inc. · Via Business Wire · August 6, 2024

Novanta to Present at Baird's 2024 Global Healthcare Conference on Tuesday, September 10, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, is scheduled to present at Baird's 2024 Global Healthcare Conference on Tuesday, September 10, 2024, in New York, NY.

By Novanta Inc. · Via Business Wire · August 5, 2024

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 6, 2024

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2024 results on Tuesday, August 6, 2024.

By Novanta Inc. · Via Business Wire · July 9, 2024

Novanta to Present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024, in White Plains, New York.

By Novanta Inc. · Via Business Wire · June 18, 2024

Novanta Announces Financial Results for the First Quarter 2024

By Novanta Inc. · Via Business Wire · May 7, 2024

Novanta to Present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024, in New York, NY.

By Novanta Inc. · Via Business Wire · May 1, 2024

Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.

By Novanta Inc. · Via Business Wire · April 19, 2024

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2024 results on Tuesday, May 7, 2024.

By Novanta Inc. · Via Business Wire · April 9, 2024

Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023

By Novanta Inc. · Via Business Wire · February 28, 2024

Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 28, 2024

By Novanta Inc. · Via Business Wire · January 29, 2024

Novanta completes acquisition of Motion Solutions

By Novanta Inc. · Via Business Wire · January 2, 2024

Novanta to Present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, Chuck Ravetto, Group President, and Ray Nash, Vice President, Corporate Finance, are scheduled to present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024, which is being held virtually.

By Novanta Inc. · Via Business Wire · December 13, 2023

Novanta to Present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024, in San Francisco, California.

By Novanta Inc. · Via Business Wire · December 11, 2023

Novanta announces agreement to acquire Motion Solutions

Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has entered into a definitive agreement to acquire Motion Solutions, a leading provider of highly engineered integrated solutions, for cash consideration of $189 million, subject to customary purchase price adjustments and closing conditions, including applicable regulatory approvals.

By Novanta Inc. · Via Business Wire · November 14, 2023

Novanta Announces Financial Results for the Third Quarter 2023

By Novanta Inc. · Via Business Wire · November 7, 2023

Novanta to Present at the Baird 2023 Global Industrial Conference on Wednesday, November 8, 2023

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the Baird 2023 Global Industrial Conference on Wednesday, November 8, 2023, in Chicago, Illinois.

By Novanta Inc. · Via Business Wire · October 11, 2023

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 7, 2023

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2023 results on Tuesday, November 7, 2023.

By Novanta Inc. · Via Business Wire · October 10, 2023

Novanta to Present at Baird's 2023 Global Healthcare Conference on Wednesday, September 13, 2023

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at Baird's 2023 Global Healthcare Conference on Wednesday, September 13, 2023, in New York, New York.

By Novanta Inc. · Via Business Wire · August 9, 2023

Novanta Announces Financial Results for the Second Quarter 2023

By Novanta Inc. · Via Business Wire · August 8, 2023